Impact of Rapid Flu Testing in BMC ED
| Status: | Completed |
|---|---|
| Conditions: | Influenza |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 7/26/2018 |
| Start Date: | February 7, 2017 |
| End Date: | December 1, 2017 |
Proposal to Evaluate the Impact of Point of Care Liat Influenza A/B Testing in the Emergency Department at Boston Medical Center
The purpose of the study is to compare Emergency Department patients who undergo influenza
testing using an FDA-approved point-of-care device (Cobas Liat Influenza A/B assay) located
in the ED, to patients whose samples are sent to the BMC central laboratory. Patients who
agree to participate will have their samples randomly assigned to be tested on either at the
core lab, or on the POC device. The current turnaround time for samples sent to the
laboratory is approximately two hours; investigators expect that the point of care device can
reduce this time. Investigators will determine if the time to disposition and the
administration of antibiotics is different in the group undergoing POC influenza testing
compared to those undergoing laboratory-based influenza testing
testing using an FDA-approved point-of-care device (Cobas Liat Influenza A/B assay) located
in the ED, to patients whose samples are sent to the BMC central laboratory. Patients who
agree to participate will have their samples randomly assigned to be tested on either at the
core lab, or on the POC device. The current turnaround time for samples sent to the
laboratory is approximately two hours; investigators expect that the point of care device can
reduce this time. Investigators will determine if the time to disposition and the
administration of antibiotics is different in the group undergoing POC influenza testing
compared to those undergoing laboratory-based influenza testing
Inclusion Criteria:
- Adult patients 21 years of age or older
- Presenting to the BMC main ED or Urgent Care area with influenza-like illness
- Physician ordered an influenza A/B diagnostic test
Exclusion Criteria:
- Previously enrolled in the study
- Any Influenza test result already available at the time approached by the ED RA
- Physician ordered comprehensive multiplex PCR respiratory pathogen assay instead of an
initial influenza A/B-only test.
- Unable to give informed consent
We found this trial at
1
site
1 Boston Medical Center Place
Boston, Massachusetts 02118
Boston, Massachusetts 02118
617.638.8000
Boston University Medical Center Boston Medical Center is an extraordinary community of health care providers...
Click here to add this to my saved trials
